Prostate Cancer Foundation
Researchers in Australia, Germany, and the US are in the early stages of developing a prostate cancer radiopharmaceutical they say could be manufactured in-house via a desktop machine.
Researchers in Australia, Germany, and the US are in the early stages of developing a prostate cancer radiopharmaceutical they say could be manufactured in-house via a desktop machine.